X @Bloomberg
Bloombergยท2025-10-15 13:30Novo Nordisk agreed to pay Omeros as much as $2.1 billion for rights to an experimental rare-disease drug https://t.co/zRf6Xw1rSi ...
Bloombergยท2025-10-15 13:30
Bloombergยท2025-10-15 13:30 Bloombergยท2025-10-15 13:30Novo Nordisk agreed to pay Omeros as much as $2.1 billion for rights to an experimental rare-disease drug https://t.co/zRf6Xw1rSi ...